Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-331-6 | CAS number: 10124-36-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The in vitro KeratinoSens test ( ARE-Nrf2 Luciferase Test Method-OECD 442) (Aubert, CiToxLAB France 2019) with cadmium sulfate was done in 2 runs.
During the first run, the following concentrations were tested: 0.98 ; 1.95 ; 3.91 ; 7.81 ; 15.6 ; 31.3 ; 62.5 ; 125 ; 250 ; 500 ; 1000 and 2000 µM.
Due to a high cytotoxicity observed in the first run, the range of concentrations was adapted in the second run as follows: 0.10; 0.20; 0.39; 0.78; 1.56; 3.13; 6.25; 12.5; 25.0; 50.0; 100; 200 µM.
At these tested concentrations:
- A high decrease in cell viability (i.e. cell viability < 70%) was noted at concentrations ≥ 31.3 µM in the first run and 25.0 µM in the second one.
-Statistically significant gene-fold inductions above the threshold of 1.5 were noted in comparison to the negative control, from the lowest tested concentration in the first run and at concentrations ≥ 0.39 µM in the second run, and up to cytotoxic concentrations in both runs,
The evaluation criteria for a positive response are therefore met in both runs.
Therefore, and in our experimental conditions, the test itemCdSO4 is positivein the KeratinoSens assay and therefore is considered to have a potential to activate the Nrf2 transcription factor.
The KeratinoSens test is part of a tiered testing strategy currently further being performed/discussed with the CRO.
Further investigation is currently ongoing checking if the other tests of the testing strategy are applicable for the substance.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- Version / remarks:
- adopted on 25th June 2018
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- activation of keratinocytes
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- lot/batch No.of test material:X09D060
- Expiration date of the lot/batch: 04 June 2020
- Purity test date:99.99%
- Description:White solid (in the powder form)
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material:
Controlled room temperature (15-25°C, ≤70% relative humidity).
- Safety precautions: Enhanced safety precautions (half mask at least with P3 filter cartridge, nitrile gloves, lab coat) were applied considering the supplied safety datasheet to assure personnel health and safety. - Details on the study design:
- Skin sensitisation (In vitro test system) : KeratinoSens assay
This in vitro test uses Human adherent HaCaT keratinocytes, an immortalized cell line. The KeratinoSens is a stably transfected cell line with a plasmid containing a luciferase gene under the transcriptional control of the SV40 origin of replication promoter. This promoter is fused with an ARE sequence.
Potential skin sensitizers are applied to the cells at 12 different concentrations and for a period of 48 hours. Sensitizers with electrophilic properties will provoke the dissociation of Keap-1 from the transcription factor Nrf2. The free Nrf2 will then bind to the ARE sequence contained in the plasmid and will therefore induce transcription of firefly luciferase. The luciferase reporter gene is under control of a single copy of the ARE element of the human AKR1C2. The luciferase production will then be measured by flash luminescence.
In parallel, cytotoxicity is measured by MTT reduction and is taken into consideration in the interpretation of the sensitisation results. This evaluation is performed in at least two independent runs. - Run / experiment:
- other: 1
- Parameter:
- other: % viability
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: A high decrease in cell viability (i.e. cell viability < 70%) was noted at concentrations ≥ 31.3 µM in the first run
- Run / experiment:
- other: 2
- Parameter:
- other: % viability
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: A high decrease in cell viability (i.e. cell viability < 70%) was noted at concentrations ≥ 25.0 µM in the second run
- Run / experiment:
- other: 1
- Parameter:
- other: gene fold induction
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Statistically significant gene-fold inductions above the threshold of 1.5 were noted in comparison to the negative control, from the lowest tested concentration (0.98µM) and up to cytotoxic concentration
- Run / experiment:
- other: 1
- Parameter:
- other: gene-fold induction
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Statistically significant gene-fold inductions above the threshold of 1.5 were noted in comparison to the negative control at concentrations ≥ 0.39 µM and up to cytotoxic concentration
- Interpretation of results:
- other: positive in the KeratinoSens assay and therefore is considered to have a potential to activate the Nrf2 transcription factor.
- Conclusions:
- Under the experimental conditions, the test item CdSO4 is positive in the KeratinoSens assay and therefore is considered to have a potential to activate the Nrf2 transcription factor.
- Executive summary:
The objective of the KeratinoSens assay is to evaluate the potential of the test item toactivate the Nrf2 transcription factor. This test is part of a tiered strategy for the evaluation of skin sensitisation potential. Therefore data generated with the present Test Guideline can be used to support the discrimination between skin sensitizers and non‑sensitizers in the context of an integrated approach to testing and assessment.
In this study 2 runs were performed.
During the first run, the following concentrations were tested: 0.98 ; 1.95 ; 3.91 ; 7.81 ; 15.6 ; 31.3 ; 62.5 ; 125 ; 250 ; 500 ; 1000 and 2000 µM.
Due to a high cytotoxicity observed in the first run, the range of concentrations was adapted in the second run as follows: 0.10; 0.20; 0.39; 0.78; 1.56; 3.13; 6.25; 12.5; 25.0; 50.0; 100; 200 µM.
At these tested concentrations:
- A high decrease in cell viability (i.e. cell viability < 70%) was noted at concentrations ≥ 31.3 µM in the first run and 25.0 µM in the second one.
- Statistically significant gene-fold inductions above the threshold of 1.5 were noted in comparison to the negative control, from the lowest tested concentration in the first run and at concentrations ≥ 0.39 µM in the second run, and up to cytotoxic concentrations in both runs,
The evaluation criteria for a positive response are therefore met in both runs.
Therefore, and in our experimental conditions, the test itemCdSO4 is positive in the KeratinoSens assay and therefore is considered to have a potential to activate the Nrf2 transcription factor.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available (further information necessary)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the KeratinoSens test so far which is part of a tiered testing strategy for the evaluation of skin sensitisation potential, it cannot be used on its own to conclude on a skin sensitisation potential. Currently further investigations are ongoing. At present cadmium sulfate has not enough data (time constrains for all tests to be done) for classification which is in line with the harmonised classification in Annex I of Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.